TY - JOUR
T1 - Diagnostic accuracy of eNose 'breathprints' for therapeutic drug monitoring of Tacrolimus trough levels in lung transplantation
AU - Wijbenga, Nynke
AU - Muller, Marjolein M.
AU - Hoek, Rogier A.S.
AU - Mathot, Bas J.
AU - Seghers, Leonard
AU - Aerts, Joachim G.J.V.
AU - de Winter, Brenda C.M.
AU - Bos, Daniel
AU - Manintveld, Olivier C.
AU - Hellemons, Merel E.
PY - 2023
Y1 - 2023
N2 - In order to prevent long-term immunity-related complications after lung transplantation, close monitoring of immunosuppressant levels using therapeutic drug monitoring (TDM) is paramount. Novel electronic nose (eNose) technology may be a non-invasive alternative to the current invasive procedures for TDM. We investigated the diagnostic and categorization capacity of eNose breathprints for Tacrolimus trough blood plasma levels (TAC
trough) in lung transplant recipients (LTRs). We performed eNose measurements in stable LTR attending the outpatient clinic. We evaluated (1) the correlation between eNose measurements and TAC
trough, (2) the diagnostic capacity of eNose technology for TAC
trough, and (3) the accuracy of eNose technology for categorization of TAC
trough into three clinically relevant categories (low: <7 µg ml
−1, medium: 7-10 µg ml
−1, and high: >10 µg ml
−1 ). A total of 186 measurements from 86 LTR were included. There was a weak but statistically significant correlation (r = 0.21, p = 0.004) between the eNose measurements and TAC
trough. The root mean squared error of prediction for the diagnostic capacity was 3.186 in the training and 3.131 in the validation set. The accuracy of categorization ranged between 45%-63% for the training set and 52%-69% in the validation set. There is a weak correlation between eNose breathprints and TAC
trough in LTR. However, the diagnostic as well as categorization capacity for TAC
trough using eNose breathprints is too inaccurate to be applicable in TDM.
AB - In order to prevent long-term immunity-related complications after lung transplantation, close monitoring of immunosuppressant levels using therapeutic drug monitoring (TDM) is paramount. Novel electronic nose (eNose) technology may be a non-invasive alternative to the current invasive procedures for TDM. We investigated the diagnostic and categorization capacity of eNose breathprints for Tacrolimus trough blood plasma levels (TAC
trough) in lung transplant recipients (LTRs). We performed eNose measurements in stable LTR attending the outpatient clinic. We evaluated (1) the correlation between eNose measurements and TAC
trough, (2) the diagnostic capacity of eNose technology for TAC
trough, and (3) the accuracy of eNose technology for categorization of TAC
trough into three clinically relevant categories (low: <7 µg ml
−1, medium: 7-10 µg ml
−1, and high: >10 µg ml
−1 ). A total of 186 measurements from 86 LTR were included. There was a weak but statistically significant correlation (r = 0.21, p = 0.004) between the eNose measurements and TAC
trough. The root mean squared error of prediction for the diagnostic capacity was 3.186 in the training and 3.131 in the validation set. The accuracy of categorization ranged between 45%-63% for the training set and 52%-69% in the validation set. There is a weak correlation between eNose breathprints and TAC
trough in LTR. However, the diagnostic as well as categorization capacity for TAC
trough using eNose breathprints is too inaccurate to be applicable in TDM.
KW - electronic nose
KW - lung transplantation
KW - therapeutic drug monitoring
UR - http://www.scopus.com/inward/record.url?scp=85169846829&partnerID=8YFLogxK
U2 - 10.1088/1752-7163/acf066
DO - 10.1088/1752-7163/acf066
M3 - Article
C2 - 37582348
AN - SCOPUS:85169846829
SN - 1752-7155
VL - 17
JO - Journal of Breath Research
JF - Journal of Breath Research
IS - 4
M1 - 046010
ER -